Nationwide trends in development of heart failure and mortality after first-time myocardial infarction 1997-2010: A Danish cohort study

European Journal of Internal Medicine

Volumn 25, Issue 8, 2014, Pages 731-738

  Gjesing, Anne ^a   Gislason, Gunnar H ^a,b,c   Køber, Lars ^b,d   Gustav Smith, J ^e,f   Christensen, Stefan Bisgaard ^a   Gustafsson, Finn ^d   Olsen, Anne Marie Schjerning ^a   Torp Pedersen, Christian ^g   Andersson, Charlotte ^a,f  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d Rigshospitalet   (Denmark)

^e LUND UNIVERSITY   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g AALBORG UNIVERSITY   (Denmark)

Author keywords

Epidemiology; Heart failure; Mortality; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT; CLOPIDOGREL; DIGOXIN; EPLERENONE; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; PRESCRIPTION DRUG; RENIN ANGIOTENSIN SYSTEM INHIBITOR; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; COMORBIDITY; DANISH CITIZEN; DENMARK; DIURETIC THERAPY; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PERCUTANEOUS CORONARY INTERVENTION; PRESCRIPTION; REGISTER; SEX RATIO; TREND STUDY; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROGNOSIS; STATISTICS AND NUMERICAL DATA;

AGED; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS;

EID: 84908134490     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.08.009     Document Type: Article

References (35)

1. L. Ryden, R. Ariniego, K. Arnman, J. Herlitz, A. Hjalmarson, and S. Holmberg A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias N Engl J Med 308 11 1983 614 618
2. N. Freemantle, J. Cleland, P. Young, J. Mason, and J. Harrison Beta blockade after myocardial infarction: systematic review and meta regression analysis BMJ 318 7200 1999 1730 1737
3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 8934 1994 1383 1389
4. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, and T.G. Cole The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 14 1996 1001 1009
5. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, and M.K. Natarajan Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 9281 2001 527 533
6. R.J. Peters, S.R. Mehta, K.A. Fox, F. Zhao, B.S. Lewis, and S.L. Kopecky Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study Circulation 108 14 2003 1682 1687
7. P.G. Steg, S.K. James, D. Atar, L.P. Badano, C. Blomstrom-Lundqvist, and M.A. Borger ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 20 2012 2569 2619
8. K.K. Ho, J.L. Pinsky, W.B. Kannel, and D. Levy The epidemiology of heart failure: the Framingham Study J Am Coll Cardiol 22 4 Suppl. A 1993 6A 13A
9. NOMESCO Classification of Surgical Procedures (NCSP), version 1.15 2011
10. D. Gaist, H.T. Sorensen, and J. Hallas The Danish prescription registries Dan Med Bull 44 4 1997 445 448
11. M. Madsen, M. Davidsen, S. Rasmussen, S.Z. Abildstrom, and M. Osler The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry J Clin Epidemiol 56 2 2003 124 130
12. T.K. Schramm, G.H. Gislason, L. Kober, S. Rasmussen, J.N. Rasmussen, and S.Z. Abildstrom Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people Circulation 117 15 2008 1945 1954
13. C. Andersson, S. Lyngbaek, C.D. Nguyen, M. Nielsen, G.H. Gislason, and L. Kober Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes JAMA 308 9 2012 882 889
14. G.H. Gislason, J.N. Rasmussen, S.Z. Abildstrom, T.K. Schramm, M.L. Hansen, and P. Buch Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes Circulation 116 7 2007 737 744
15. C. Andersson, M.L. Norgaard, P.R. Hansen, E.L. Fosbol, M. Schmiegelow, and P. Weeke Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study Eur J Heart Fail 12 12 2010 1333 1338
16. T. Kumler, G.H. Gislason, V. Kirk, M. Bay, O.W. Nielsen, and L. Kober Accuracy of a heart failure diagnosis in administrative registers Eur J Heart Fail 10 7 2008 658 660
17. S. Eshaghian, T.B. Horwich, and G.C. Fonarow Relation of loop diuretic dose to mortality in advanced heart failure Am J Cardiol 97 12 2006 1759 1764
18. F.A. Spencer, T.E. Meyer, R.J. Goldberg, J. Yarzebski, M. Hatton, and D. Lessard Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective J Am Coll Cardiol 34 5 1999 1378 1387
19. J.P. Hellermann, T.Y. Goraya, S.J. Jacobsen, S.A. Weston, G.S. Reeder, and B.J. Gersh Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol 157 12 2003 1101 1107
20. J.A. Ezekowitz, P. Kaul, J.A. Bakal, P.W. Armstrong, R.C. Welsh, and F.A. McAlister Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction J Am Coll Cardiol 53 1 2009 13 20
21. D.J. Kelly, T. Gershlick, B. Witzenbichler, G. Guagliumi, M. Fahy, and G. Dangas Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial Am Heart J 162 4 2011 663 670
22. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators Lancet 354 9180 1999 708 715
23. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators Lancet 354 9180 1999 701 707
24. H.R. Andersen, T.T. Nielsen, K. Rasmussen, L. Thuesen, H. Kelbaek, and P. Thayssen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 8 2003 733 742
25. F. Zijlstra, J.C. Hoorntje, M.J. de Boer, S. Reiffers, K. Miedema, and J.P. Ottervanger Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction N Engl J Med 341 19 1999 1413 1419
26. R.S. Velagaleti, M.J. Pencina, J.M. Murabito, T.J. Wang, N.I. Parikh, and R.B. D'Agostino Long-term trends in the incidence of heart failure after myocardial infarction Circulation 118 20 2008 2057 2062
27. K.A. Fox, P.G. Steg, K.A. Eagle, S.G. Goodman, F.A. Anderson Jr., and C.B. Granger Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 17 2007 1892 1900
28. M. Shafazand, A. Rosengren, G. Lappas, K. Swedberg, and M. Schaufelberger Decreasing trends in the incidence of heart failure after acute myocardial infarction from 1993-2004: a study of 175,216 patients with a first acute myocardial infarction in Sweden Eur J Heart Fail 13 2 2011 135 141
29. F. Najafi, A.J. Dobson, M. Hobbs, and K. Jamrozik Late-onset heart failure after myocardial infarction: trends in incidence and survival Eur J Heart Fail 10 8 2008 765 771
30. P.G. Steg, B. Iung, L.J. Feldman, D. Cokkinos, J. Deckers, and K.A. Fox Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes Heart 88 1 2002 20 24
31. S.T. Nauta, J.W. Deckers, R.M. van der Boon, K.M. Akkerhuis, and R.T. van Domburg Risk factors for coronary heart disease and survival after myocardial infarction Eur J Prev Cardiol 21 5 2012 576 583
32. T. Jernberg, P. Johanson, C. Held, B. Svennblad, J. Lindback, and L. Wallentin Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction JAMA 305 16 2011 1677 1684
33. W.J. Flu, J.P. van Kuijk, W. Galal, R. Kuiper, L.L. van de Ven, and H.J. Verhagen Prevalence and pharmacological treatment of left-ventricular dysfunction in patients undergoing vascular surgery Eur J Heart Fail 12 3 2010 288 293
34. J.J. McMurray, P.E. Carson, M. Komajda, R. McKelvie, M.R. Zile, and A. Ptaszynska Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial Eur J Heart Fail 10 2 2008 149 156
35. S.Z. Abildstrom, S. Rasmussen, and M. Madsen Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed Eur Heart J 26 10 2005 990 995